Idiopathic Hypertrophic Pachymeningitis: Does Earlier Treatment Improve Outcome?

Emilia Rizzo1,2, Ailsa Elizabeth Ritchie3, Vinay Shivamurthy4

  • 1Faculty of Medicine and Surgery, University of Catania, Piazza dell'Università 2, 95124 Catania, Italy.

Insights

Early steroid treatment is crucial for children with idiopathic hypertrophic pachymeningitis, a rare dural thickening disorder. Prompt intervention may significantly improve outcomes and prevent long-term complications.

Area of Science:

  • Neurology
  • Pediatrics
  • Inflammatory Disorders

Background:

  • Hypertrophic pachymeningitis is a rare dural thickening disorder, predominantly reported in adults.
  • Pediatric cases are exceptionally uncommon, necessitating further investigation into this condition in children.

Observation:

  • A 14-year-old boy presented with severe headache and declining vision due to idiopathic hypertrophic pachymeningitis.
  • A review of eleven pediatric cases revealed that steroid treatment often leads to positive responses.
  • Delayed steroid initiation was associated with incomplete recovery in some cases, potentially impacting visual outcomes.

Findings:

  • Steroid therapy demonstrated efficacy in managing pediatric hypertrophic pachymeningitis.
  • Early intervention with steroids correlated with better patient outcomes.
  • Delayed treatment initiation was linked to poorer recovery, as observed in the presented case.

Implications:

  • Prompt diagnosis and early initiation of steroid therapy are vital for improving outcomes in pediatric hypertrophic pachymeningitis.
  • This underscores the importance of considering hypertrophic pachymeningitis in children presenting with relevant neurological symptoms.
  • Further research into pediatric hypertrophic pachymeningitis is warranted to optimize management strategies.